|
Market Closed -
Nasdaq
16:00:00 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 218.01 USD | -7.82% |
|
-3.11% | +639.27% |
| 10-16 | Moderna Insider Sold Shares Worth $17,013,538, According to a Recent SEC Filing | MT |
| 10-15 | Global tech rout loses steam | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 87.04B | - | ||||
| 1,120B | |||||
| 616B | |||||
| 504B | |||||
| 367B | |||||
| 360B |
- Stock Market
- Stocks
- MRNA Stock
- Charts Moderna, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
